Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 35 Neoplasms 23 Motor Activity 11 Stomach Neoplasms 7 Pain, Postoperative 7 Lung Neoplasms 7 Fatigue 7 Colorectal Neoplasms 7 Pain 5 Anxiety Disorders 5 Polycystic Ovary Syndrome 4 Depression 4 Carcinoma, Hepatocellular 4 Uterine Cervical Neoplasms 3 Thyroid Neoplasms 3 Stomatitis 3 Sleep Initiation and Maintenance Disorders 3 Rectal Neoplasms 3 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Malnutrition 3 Liver Neoplasms 3 Leukemia, Myeloid, Acute 3 Colonic Neoplasms 3 Agnosia 3 Vomiting 2 Urinary Incontinence 2 Squamous Cell Carcinoma of Head and Neck 2 Parasomnias 2 Ovarian Neoplasms 2

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 9 Ciprofloxacin 7 gamma-Globulins 3 Voriconazole 3 Fluconazole 3 Daptomycin 3 Antibiotic Prophylaxis 3 Amoxicillin-Potassium Clavulanate Combination 3 Whole-Body Irradiation 2 Vancomycin 2 Trimethoprim 2 Sulfamethoxazole 2 Saline Solution 2 Ribavirin 2 Peripheral Blood Stem Cell Transplantation 2 Pentetic Acid 2 Melphalan 2 Itraconazole 2 Immunoglobulins, Intravenous 2 Fosfomycin 2 Ethanol 2 Cyclophosphamide 2 Cefazolin 2 Caspofungin 2 ziprasidone 1 tocilizumab 1 telavancin 1 telaprevir 1 talquetamab 1 soybean oil, phospholipid emulsion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Infections × Control Groups × Clear all

NCT06655506 2024-10-23

ERGO

National and Kapodistrian University of Athens

Infections, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡